Background/Aims: In this paper we aim to resolve the phonological status of utterance-initial rises in Spanish wh-questions. Methods/Analysis 1: In analysis 1 we examine the scaling and alignment properties of utterance-initial rises produced by 14 speakers of Peninsular Spanish. Results/Analysis 1: The results provide evidence for a single bitonal pitch accent at the left periphery (L + <H*) despite multiple options at the right periphery. Conclusion/Analysis 1: Our analysis, relying on the notion of sparse tonal specification, helps to explain Sp_ToBI transcribers' past inconsistencies in labeling wh-question initial rises. Methods/Analysis 2: In analysis 2 we tested whether there are scaling differences between the wh-question contours produced in analysis 1 and statement contours produced by the same 14 speakers. Results/Analysis 2: We showed that speakers scale utterance-initial peaks higher in statements, and that they scale utterancefinal peaks higher in wh-questions. Conclusion/Analysis 2: This finding is incompatible with the notion that speakers of Spanish use a higher F0 level from the start of the utterance to distinguish questions from statements.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.